Literature DB >> 3226529

A comparison of assessment techniques measuring the effects of methylphenidate, secobarbital, diazepam and diphenhydramine in abstinent alcoholics.

T P Miller1, J L Taylor, J R Tinklenberg.   

Abstract

In two studies, we studied the comparative sensitivity of different subjective and objective measures to methylphenidate (10 and 20 mg) and secobarbital (100 mg) versus placebo, and diphenhydramine (50 mg) and diazepam (10 and 20 mg) versus placebo in abstinent alcoholics. Subjective measures used were the Visual Analog Mood Scale and the Profile of Mood States. Objective measures were the Stroop and two microcomputer-controlled tasks developed in our lab - a dual pursuit tracking/reaction time task (P-Trak) and a reaction time task with regular and irregular preparatory intervals (PI) of varying length (Reactest). In addition, several baseline measures (Eysenck Personality Inventory, Spielberger State-Trait Anxiety Inventory and NIMH Mood Scale Elderly) were evaluated for their correlation to drug response. All three central nervous system depressants impaired performance on Reactest at the longer PIs and showed a main effect with irregular PIs, but only the 20-mg dose of diazepam impaired reaction time at the shortest PI and showed a main effect with regular PIs. On P-Trak, secobarbital and diazepam 20 mg impaired both tracking and reaction time, while methylphenidate 20 mg improved only the reaction time component. Only diazepam 20 mg affected mood. No effects were noted on the Stroop. The implications of these findings are discussed. Both P-Trak and Reactest with long PIs were more sensitive than VAMS, POMS or Stroop to drug effects. As lower doses of central nervous system depressants impaired reaction time only with longer PIs and showed a main effect only with irregular PIs, cognitive effects of these drugs may be missed if only subjective or short, regular PI tasks are examined.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3226529     DOI: 10.1159/000118441

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  23 in total

1.  Effects of lorcaserin on oxycodone self-administration and subjective responses in participants with opioid use disorder.

Authors:  Laura Brandt; Jermaine D Jones; Suky Martinez; Jeanne M Manubay; Shanthi Mogali; Tatiana Ramey; Frances R Levin; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2020-01-17       Impact factor: 4.492

2.  Amphetamine self-administration by humans: modulation by contingencies associated with task performance.

Authors:  S D Comer; M Haney; R W Foltin; M W Fischman
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

3.  Depot naltrexone: long-lasting antagonism of the effects of heroin in humans.

Authors:  Sandra D Comer; Eric D Collins; Herbert D Kleber; Elie S Nuwayser; James H Kerrigan; Marian W Fischman
Journal:  Psychopharmacology (Berl)       Date:  2001-11-01       Impact factor: 4.530

4.  Comparison of intranasal methamphetamine and d-amphetamine self-administration by humans.

Authors:  Matthew G Kirkpatrick; Erik W Gunderson; Chris-Ellyn Johanson; Frances R Levin; Richard W Foltin; Carl L Hart
Journal:  Addiction       Date:  2012-04       Impact factor: 6.526

5.  Comparison of intravenous buprenorphine and methadone self-administration by recently detoxified heroin-dependent individuals.

Authors:  Sandra D Comer; Maria A Sullivan; Ellen A Walker
Journal:  J Pharmacol Exp Ther       Date:  2005-09-06       Impact factor: 4.030

6.  Reinforcing effects of oral Delta9-THC in male marijuana smokers in a laboratory choice procedure.

Authors:  Carl L Hart; Margaret Haney; Suzanne K Vosburg; Sandra D Comer; Richard W Foltin
Journal:  Psychopharmacology (Berl)       Date:  2005-04-14       Impact factor: 4.530

7.  Smoked marijuana attenuates performance and mood disruptions during simulated night shift work.

Authors:  Diana R Keith; Erik W Gunderson; Margaret Haney; Richard W Foltin; Carl L Hart
Journal:  Drug Alcohol Depend       Date:  2017-06-28       Impact factor: 4.492

8.  Methamphetamine attenuates disruptions in performance and mood during simulated night-shift work.

Authors:  Carl L Hart; Amie S Ward; Margaret Haney; Jennifer Nasser; Richard W Foltin
Journal:  Psychopharmacology (Berl)       Date:  2003-05-07       Impact factor: 4.530

9.  Methamphetamine self-administration by humans subjected to abrupt shift and sleep schedule changes.

Authors:  Matthew G Kirkpatrick; Margaret Haney; Suzanne K Vosburg; Sandra D Comer; Richard W Foltin; Carl L Hart
Journal:  Psychopharmacology (Berl)       Date:  2008-12-04       Impact factor: 4.530

10.  Residual effects of intranasal methamphetamine on sleep, mood, and performance.

Authors:  Audrey Y Perez; Matthew G Kirkpatrick; Erik W Gunderson; Gina Marrone; Rae Silver; Richard W Foltin; Carl L Hart
Journal:  Drug Alcohol Depend       Date:  2007-12-19       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.